Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou don't need to eat before taking Mounjaro. The injection is not food-dependent — you can take it on an empty stomach, after a meal, or at any point in the day, and the medicine works the same way regardless. That said, the timing of your meals in relation to the injection does affect how comfortable you feel, particularly in the first few weeks of treatment. Mounjaro is a prescription-only medicine, and how you fit it into your daily routine is something your prescriber can tailor to you after a clinical assessment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the most common misunderstanding, and it usually comes from mixing up Mounjaro with oral medicines that need food to protect the stomach lining. Mounjaro is a subcutaneous injection (it goes under the skin of the abdomen, thigh or upper arm) so it bypasses the digestive process entirely on the way in. Food in your stomach has no bearing on how the medicine is absorbed or how well it works.
The confusion is understandable. Many people move to Mounjaro from daily tablets or have read about oral GLP-1 medicines, such as the newly approved Wegovy tablet, which must be taken on a completely empty stomach and requires a 30-minute wait before food. Mounjaro has no such rule. There is no window to observe, no 30-minute fast, no required meal before or after.
What does matter is how a large meal interacts with tirzepatide's mechanism. The drug slows gastric emptying, food moves through the stomach more slowly than usual. If you inject and then immediately eat a rich or heavy meal, the combination can make nausea more pronounced, particularly in the early weeks when your system is still adjusting. That is a comfort issue, not a dosing issue. If you are wondering whether you should eat before taking Mounjaro, the answer depends more on how you feel than on any clinical requirement. The question of whether to take Mounjaro with food is really a question about managing how you feel.
Because tirzepatide slows digestion, many people find that the hours immediately surrounding their weekly injection are worth keeping lighter. Injecting when your stomach is relatively settled (not immediately after a large Sunday roast, not just before a big family meal) gives the medicine the smoothest start.
A simple habit that takes under a minute: before you inject each week, think about what the next two hours look like. If a big meal is imminent, consider shifting the injection to earlier in the day or to a different time of day altogether. Mounjaro is once-weekly, so the exact clock time is flexible, consistency across weeks matters more than the specific hour.
Smaller, more frequent meals often sit more comfortably than large ones when you are on tirzepatide. This is partly the medicine's effect on appetite (hunger signals reduce, so large portions feel less natural anyway) and partly the slower gastric emptying. For more detail on meal structure while on treatment, the food choices that work alongside Mounjaro are worth reading through separately.
High-fat, very rich meals are the category most associated with nausea on treatment days. Bland, protein-forward, moderate portions tend to sit more easily. This is not a clinical rule, it's what the evidence on GI side effects suggests and what many patients report. The NHS tirzepatide medicine page covers the common GI side effects and their typical trajectory clearly, and is worth bookmarking.
Nausea is the most frequently reported side effect of tirzepatide, and it is most noticeable in the first four weeks of treatment and briefly after each dose increase. For most people it settles, often within days to a couple of weeks. Meal timing is one of the factors you can control. Dose timing is another. Some people prefer injecting in the evening so that any initial queasiness passes overnight; others prefer the morning once they are confident the medicine agrees with them.
Vomiting, diarrhoea and constipation are also reported, typically mild and self-limiting. Staying hydrated matters more than people realise, particularly if nausea puts you off drinks as well as food. If GI symptoms are severe or persistent, that is a conversation for your prescriber, not something to manage alone by adjusting when you eat.
Severe, persistent stomach pain that travels to the back (with or without vomiting) needs urgent medical attention, as it may be a sign of pancreatitis. The MHRA highlighted acute pancreatitis as a known but uncommon risk in its Drug Safety Update communications for GLP-1 medicines. Adjusting meal timing will not resolve this, seek help promptly.
For a fuller picture of how diet and treatment interact week to week, the guide to eating well on Mounjaro covers protein, fibre and hydration in practical terms. And if you are still working out the right moment in your weekly routine to inject, choosing the best time before or after food goes into those trade-offs in more detail.
Mounjaro is a prescription-only medicine licensed for weight management alongside a reduced-calorie diet and increased physical activity, for adults with a BMI of 30 or above, or 27 and above with a weight-related health condition. Lower thresholds apply for some ethnic backgrounds under UK guidance. Being within those parameters does not automatically mean it is the right treatment, a prescriber assesses the full picture, including medications that could interact, existing health conditions and your personal circumstances.
The Mounjaro overview covers the licence, the clinical evidence and what treatment typically looks like from the first pen onward. Our clinical team reviews every consultation personally, not an algorithm. Decisions about dose, timing and how to manage any side effects are made at that clinical level, not built into a one-size app.
If you have questions about whether Mounjaro is appropriate for your situation, check your eligibility through a free consultation. There is no obligation, and the review happens the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.